Vulnerabilities

Vulnerability · CVE-2025-20041

Uncontrolled search path for some Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 may allow an aut

Published May 13, 2025 · catalog updated May 14, 2025 · Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics

Check this week

CVE-2025-20041 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.4
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
16.00%
Remediation
Version ranges on file
Affected products
vendor n/a Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252

Uncontrolled search path for some Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 may allow an authenticated user to potentially enable escalation of privilege via local access.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor n/a Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252before version 32.0.101.6325/32.0.101.6252

How to fix CVE-2025-20041

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-20041 is not in CISA KEV. FIRST estimates a 16.00% chance of exploitation in the next 30 days. Check whether you run Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics.

Which versions are affected?

Compare what you have installed with n/a Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 before version 32.0.101.6325/32.0.101.6252. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 16.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 13, 2025 · EUVD

    Detected

    Uncontrolled search path for some Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 may allow an authenticated user to potentially enable escalation of privilege via local access.

  2. May 14, 2025 · EUVD

    Fix available

    n/a Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 fixed in version 32.0.101.6325/32.0.101.6252

  3. May 14, 2025 · EUVD

    Updated

    Uncontrolled search path for some Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 may allow an authenticated user to potentially enable escalation of privilege via local access.

Sources

  • CVE.orgVulnerability recordCVE-2025-20041

    Official CVE identifier

    cve.org
  • EUVDVulnerability recordEUVD-2025-14584

    Uncontrolled search path for some Intel(R) Graphics software for Intel(R) Arc™ graphics and Intel(R) Iris(R) Xe graphics before version 32.0.101.6325/32.0.101.6252 may allow an authenticated user to potentially enable escalation of privilege via local access.

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 17, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.